Raloxifene

Raloxifene is a pharmaceutical-grade active ingredient classified as a Selective Estrogen Receptor Modulator (SERM). Mediocon Inc supplies high-purity Raloxifene API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Raloxifene is a second-generation SERM that acts as an estrogen agonist in bone and cardiovascular tissues while acting as an estrogen antagonist in breast and uterine tissues. It is FDA-approved for the prevention and treatment of osteoporosis in postmenopausal women and for reducing the risk of invasive breast cancer.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Osteoporosis prevention and treatment in postmenopausal women
• Breast cancer risk reduction
• Bone density maintenance in HRT
• Cardiovascular risk profile improvement

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings